Proceeding contribution from Paul Burstow (Liberal Democrat) in the House of Commons on Tuesday, 6 December 2005. It occurred during Adjournment debate on Medicine Reviews (Older People).
Medicine Reviews (Older People)
That is one of my main concerns, and a key issue in the executive summary of both parts of the evaluation. At the heart of the problem is the fact that a clear working definition of a medication review was not in place when the QOF and the NSF were set. Without such a definition, it is difficult to know what one is measuring and thus be confident that progress is under way.
Secondary information
- Type
- Proceeding contribution
- Reference
- 440 c848
- Session
- 2005-06
- Chamber / Committee
- House of Commons chamber
- Subjects
- Doctors Finance Drugs NHS Prescription drugs Older people Prescriptions Reviews
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2024-04-21 12:36:14 +0100
- URI
- http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_284319
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_284319
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/hansard/CONTRIBUTION_284319